Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | F13A1 | P00488 | 3/20 | 0.53 |
| ▸ | PDE2A | O00408 | 1/20 | 0.52 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.52 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.52 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29866085 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL10439619 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL31156411 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL710798 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL8434872 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL10439755 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL10439522 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL2107915 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL10439620 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 | |
| SCHEMBL2536989 | 0.93 | CYP1A2 (0.87) | CYP1A2MAPTRXFP1HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9227922-B2 | Amorphous amides | XEROX CORPORATION (US) | 2016-01-05 | — | — | US | disclosed |
| US-20150105587-A1 | Amorphous Amides | XEROX CORPORATION (US) | 2015-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150105587-A1 | Amorphous Amides | ALK, ACVR2A, ARG1 | CYP1A2 91/4885MAPT 982/4885RXFP1 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.